Abstract:An amino‐functionalization strategy is introduced to fabricate a library of kidney‐targeting fluorophores NHcy with tunable emission ranging from NIR‐I to NIR‐II. Building on this NIR‐II kidney‐targeting platform, the first NIR‐II small‐molecule kidney‐targeting pH probe NIR‐II‐pH is developed, which exhibits a desirable kidney distribution after tail intravenous injection and achieves precise visualization of metabolic acidosis induced by cisplatin and renal I/R injury. The development of rapidly distributed and retained probes within the kidneys is important for accurately diagnosing kidney diseases. Although molecular imaging shows the potential for non‐intrusively interrogating kidney disease‐related biomarkers, the limited kidney contrast of many fluorophores, owing to their relatively low distribution in the kidney, hinders their effectiveness for kidney disease detection. Herein, for the first time, an amino‐functionalization strategy is proposed to construct a library of kidney‐targeting fluorophores NHcy with tunable emissions from NIR‐I to NIR‐II. Among these, NHcy‐8 is the first small‐molecule NIR‐II dye without a renal clearance moiety, designed specifically for kidney‐targeting imaging. Building on this class of NIR‐II fluorophore, the first NIR‐II small‐molecule kidney‐targeting pH probe NIR‐II‐pH is developed, which exhibits a desirable kidney distribution after intravenous injection and is fluorescent only after activation by acidosis. NIR‐II in vivo fluorescence/photoacoustic imaging of kidney disease models induced by cisplatin and renal I/R injury using NIR‐II‐pH reveals increasingly severe metabolic acidosis as the disease progressed, enabling sensitive detection of the onset of acidosis 36 h (cisplatin group) earlier than clinical methods. Thus, this study introduces a practical NIR‐II kidney‐targeting probe and provides a useful molecular blueprint for guiding kidney‐targeting NIR‐II fluorophores as diagnostic aids for kidney diseases.

High‐contrast Noninvasive Imaging of Kidney Clearance Kinetics Enabled by Renal Clearable Nanofluorophores

Noninvasive Staging of Kidney Dysfunction Enabled by Renal-Clearable Luminescent Gold Nanoparticles

Bright and Renal-Clearable Au Nanoclusters with NIR-II Excitation and Emission for High-Resolution Fluorescence Imaging of Kidney Dysfunction

Renal-clearable Nanoprobes for Optical Imaging and Early Diagnosis of Diseases

An inherently kidney-targeting near-infrared fluorophore based probe for early detection of acute kidney injury

Renal clearing carbon dots-based near-infrared fluorescent super-small nanoprobe for renal imaging

A Bright, Renal‐Clearable NIR‐II Brush Macromolecular Probe with Long Blood Circulation Time for Kidney Disease Bioimaging

Engineering of Kidney‐Targeting Fluorophores with Tunable Emission from NIR‐I to NIR‐II for Early Diagnosis of Kidney Disease

Developing A Bright Nir-Ii Fluorophore With Fast Renal Excretion And Its Application In Molecular Imaging Of Immune Checkpoint Pd-L1

Enhanced Ultrasound Contrast of Renal-Clearable Luminescent Gold Nanoparticles

Non-small Nanoprobes Based on FDA-approval Formulation for NIR-II Imaging and Detection of Drug-induced Acute Kidney Injury

Fluoro‐Photoacoustic Polymeric Renal Reporter for Real‐Time Dual Imaging of Acute Kidney Injury

Renal-Clearable Probe with Water Solubility and Photostability for Biomarker-Activatable Detection of Acute Kidney Injuries Via NIR-II Fluorescence and Optoacoustic Imaging

Detection of Kidney Dysfunction through In Vivo Magnetic Resonance Imaging with Renal-Clearable Gadolinium Nanoprobes

Near‐Infrared Chemiluminescent Reporters for In Vivo Imaging of Reactive Oxygen and Nitrogen Species in Kidneys

Ultrabright Renal-Clearable Cyanine-Protein Nanoprobes for High-Quality NIR-II Angiography and Lymphography.

Near-Infrared Fluorescence Probes for Monitoring and Diagnosing Nephron-Urological Diseases

Engineering Cyanine‐ and Hemicyanine‐Based Probes for Optical Imaging of Kidney Diseases

Bright, Photostable, and Long-Circulating NIR-II Nanoparticles for Wholeprocess Monitoring and Evaluation of Renal Transplantation

High-Performance Renal Imaging With A Radiolabeled Non-Excretable Chimeric Fusion Protein

In Vivo X-ray Imaging of Transport of Renal Clearable Gold Nanoparticles in the Kidneys.